Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.

MLA

Guerrini, Marco, et al. “Oversulfated Chondroitin Sulfate Is a Contaminant in Heparin Associated with Adverse Clinical Events.” Nature Biotechnology, vol. 26, no. 6, June 2008, pp. 669–75. EBSCOhost, https://doi.org/10.1038/nbt1407.

APA

Guerrini, M., Beccati, D., Shriver, Z., Naggi, A., Viswanathan, K., Bisio, A., Capila, I., Lansing, J. C., Guglieri, S., Fraser, B., Al-Hakim, A., Gunay, N. S., Zhang, Z., Robinson, L., Buhse, L., Nasr, M., Woodcock, J., Langer, R., Venkataraman, G., & Linhardt, R. J. (2008). Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nature Biotechnology, 26(6), 669–675. https://doi.org/10.1038/nbt1407

Chicago

Guerrini, Marco, Daniela Beccati, Zachary Shriver, Annamaria Naggi, Karthik Viswanathan, Antonella Bisio, Ishan Capila, et al. 2008. “Oversulfated Chondroitin Sulfate Is a Contaminant in Heparin Associated with Adverse Clinical Events.” Nature Biotechnology 26 (6): 669–75. doi:10.1038/nbt1407.